Low Rates of Breakthrough COVID-19 Infection After SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease
Author(s) -
Kimberly N. Weaver,
Xian Zhang,
Xiangfeng Dai,
Wenli Chen,
Runa Watkins,
Jeremy Adler,
Marla C. Dubinsky,
Arthur Kastl,
Athos Bousvaros,
Jennifer Strople,
Raymond K. Cross,
Peter Higgins,
Ryan C. Ungaro,
Meenakshi Bewtra,
Emanuelle Bellaguarda,
Francis A. Farraye,
Riley Craig,
Cristian Hernandez,
Margie Boccieri,
Ann M. Firestine,
Kelly Chun,
Millie D. Long,
Michael D. Kappelman
Publication year - 2022
Publication title -
inflammatory bowel diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.932
H-Index - 146
eISSN - 1536-4844
pISSN - 1078-0998
DOI - 10.1093/ibd/izac138
Subject(s) - medicine , inflammatory bowel disease , covid-19 , coronavirus , vaccination , disease , cohort , immunology , virology , infectious disease (medical specialty) , outbreak
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom